検索結果

adquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 ...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

The success of our premier line of ophthalmological drugs has launched our entry into other promising fields of medicine Senju Pharmaceutical greatly values the clinical experience of medical professi...

Management Policy | About Senju | SENJU Pharmaceutical

valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...

Overseas Activities | SENJU Pharmaceutical

nd pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the era o...

Overseas Activities | SENJU Pharmaceutical

nd pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the era o...